129 related articles for article (PubMed ID: 38386197)
21. Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center.
Thibodeau S; Meem M; Hopman W; Sandhu S; Zalay O; Fung AS; Kartolo A; Digby GC; Al-Ghamdi S; Robinson A; Ashworth A; Owen T; Mahmud A; Tam K; Olding T; de Moraes FY
Cancer Treat Res Commun; 2023; 36():100747. PubMed ID: 37531737
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
[TBL] [Abstract][Full Text] [Related]
23. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.
Moumtzi D; Lampaki S; Zarogoulidis P; Porpodis K; Lagoudi K; Hohenforst-Schmidt W; Pataka A; Tsiouda T; Zissimopoulos A; Lazaridis G; Karavasilis V; Timotheadou H; Barbetakis N; Pavlidis P; Kontakiotis T; Zarogoulidis K
Ann Transl Med; 2016 May; 4(9):161. PubMed ID: 27275474
[TBL] [Abstract][Full Text] [Related]
25. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
26. Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
Su SF; Hu YX; Ouyang WW; Lu B; Ma Z; Li QS; Li HQ; Geng YC
BMC Cancer; 2013 Oct; 13():474. PubMed ID: 24118842
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients.
Li XL; Yao ZH; Wan YY; Mou XY; Ni YH; Sun EL; Zhang D; Lin DJ
Neoplasma; 2019 Nov; 66(6):971-977. PubMed ID: 31390870
[TBL] [Abstract][Full Text] [Related]
28. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.
Wu KL; Tsai MJ; Yang CJ; Chang WA; Hung JY; Yen CJ; Shen CH; Kuo TY; Lee JY; Chou SH; Liu TC; Chong IW; Huang MS
Lung Cancer; 2015 May; 88(2):187-94. PubMed ID: 25747806
[TBL] [Abstract][Full Text] [Related]
29. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
31. [The impact of the highest mediastinal lymph node metastasis on postoperative recurrence and survival in non-small cell lung cancer patients].
Liu JW; Zhang XN; Lin G; Li J
Zhonghua Wai Ke Za Zhi; 2023 Dec; 61(12):1086-1092. PubMed ID: 37932145
[No Abstract] [Full Text] [Related]
32. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis.
Hung JJ; Jeng WJ; Hsu WH; Wu KJ; Chou TY; Hsieh CC; Huang MH; Liu JS; Wu YC
Thorax; 2010 Mar; 65(3):241-5. PubMed ID: 20335294
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
34. Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.
Monnet I; Audigier-Valette C; Girard N; Vergnenègre A; Molinier O; Souquet PJ; Blanchon F; Bonnetain F; Taguieva-Pioger N; Lamour C; Wislez M
Lung Cancer; 2016 Aug; 98():84-90. PubMed ID: 27393512
[TBL] [Abstract][Full Text] [Related]
35. Five-year survival of resectable stage IIIA non-small cell lung cancer in Brazil.
de Barros MLGP; Silva VG; Moreira FR; Perez SV; Younes RN; Abrão FC
J Surg Oncol; 2023 Dec; 128(7):1195-1204. PubMed ID: 37448240
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
37. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
38. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Moon MH; Moon YK; Moon SW
Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
[TBL] [Abstract][Full Text] [Related]
39. Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
Zheng D; Ye T; Hu H; Zhang Y; Sun Y; Xiang J; Chen H
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1814-1822.e4. PubMed ID: 29221745
[TBL] [Abstract][Full Text] [Related]
40. The effect of platelet-to-lymphocyte ratıo (PLR) and glasgow prognostıc score (GPS) on recurrence, and survıval ın patıents undergoıng lobectomy for early-stage non-small cell lung cancer (NSCLC).
Agaoglu Sanli B; Gulmez B; Yazgan S; Ucvet A
Updates Surg; 2024 Apr; 76(2):631-639. PubMed ID: 37853294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
